Robert Kramer Net Worth & Insider Trades

Robert Kramer - President and CEO, Emergent Biosolutions Inc

As of March 2, 2022

What is Robert Kramer's Net Worth?

The current estimated net worth of Emergent Biosolutions Inc's President and CEO, Robert Kramer, is estimated to be about $19.77M . Robert Kramer owns about 139,210 units of Emergent Biosolutions Inc common stock. In the last 16 years at Emergent Biosolutions Inc, Robert Kramer has sold an estimated value of $20.53M worth.

What is Robert Kramer's Past Insider Trading?

Robert Kramer's largest purchase order was 45,397 units , worth over $1.4M on February 9, 2021. Robert Kramer's largest sale order was 45,397 units , worth over $5.45M on February 9, 2021. In total, Robert Kramer has made about 50 transactions over 16 years of their time at Emergent Biosolutions Inc. Robert Kramer usually trades in June, with the busiest year in 2007.

Robert Kramer

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Robert Kramer's Salary in 2020?

As President and CEO of Emergent Biosolutions Inc, Robert Kramer has a total base salary of $893,860 . Robert Kramer received compensation valued at about $5,569,978 in 2020 after becoming President and CEO. The vast majority of their compensation came in the form of stock awards of $2,050,007 , option awards of $1,392,416 , other earnings, plans or compensations of $1,225,020 , and other compensation of $8,675 .

What is Robert Kramer's' Mailing Address?

  • Mailing address is 2273 Research Blvd, Suite 400 Rockville MD 20850 MD

Emergent Biosolutions Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Fuad El-Hibri 2020 $1,192,202 $1,200,046 $815,051 - $6,185 $3,213,484
Fuad El-Hibri 2019 $1,131,577 $1,099,949 $773,813 - $4,723 $3,010,062
Fuad El-Hibri 2018 $1,047,031 $957,456 $957,481 - $8,250 $2,970,218
Robert Kramer 2020 $893,860 $2,050,007 $1,392,416 $1,225,020 $8,675 $5,569,978
Robert Kramer 2019 $678,021 $1,439,958 $1,012,999 $557,108 $5,735 $3,693,821
Robert Kramer 2018 $549,047 $649,930 $649,980 $538,807 $8,983 $2,396,747
Richard Lindahl 2020 $549,390 $749,998 $509,425 $462,012 $10,475 $2,281,300
Richard Lindahl 2019 $514,826 $619,984 $436,154 $297,429 $9,104 $1,877,497
Richard Lindahl 2018 $365,393 $557,438 $351,101 $330,007 $8,514 $1,612,453
Adam Havey 2020 $546,507 $700,047 $475,413 $445,204 $8,357 $2,175,528
Adam Havey 2019 $484,120 $619,984 $436,154 $279,579 $25,530 $1,845,367
Adam Havey 2018 $480,728 $499,974 $359,784 $310,212 $8,383 $1,659,081
Atul Saran 2020 $528,803 $700,047 $475,413 $445,204 $9,565 $2,159,032
Atul Saran 2019 $503,774 $619,984 $436,154 $293,567 $9,500 $1,862,979
Atul Saran 2018 $488,730 $527,475 $379,572 $293,567 $8,683 $1,698,027
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1367644/000136764421000061/ebsi2021asmproxystatement.htm

What are Emergent Biosolutions Inc's Past Insider Trades?

Emergent Biosolutions Inc's most recent insider trade came on November 29, 2022 by Richard S. Lindahl Attorney-In-Fact who sold 1,912 units worth $22.83K . In the last 16 years, insiders at Emergent Biosolutions Inc have sold an estimated value of $238.09M and bought an estimated value of $38.64M worth of shares. Insider trading is most common in May, with the busiest year in 2007. The most active traders at the company are Fuad Elhibri, Director,  Daniel Abdunnabi, CEO,  and Robert Kramer, President and CEO .

Emergent BioSolutions Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1